EUVIMEDEUVIMED entdecken
Übersichtsarbeit

A comprehensive review of multi-target directed ligands in the treatment of Alzheimer’s disease

Chandni Pathak, Uma D Kabra

Bioorganic Chemistry · 2024-03 · 144 · 107152

DOI: 10.1016/j.bioorg.2024.107152 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Bioorganic Chemistry, 2024-03. Verfasst von Chandni Pathak und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Chemistry, Parul Institute of Pharmacy, Parul University, Vadodara, Gujarat, India. Hauptthemen laut MEDLINE: Alzheimer Disease. Die Arbeit wurde bisher 128-mal zitiert (Crossref) und nennt 120 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Alzheimer's disease (AD) is the most common form of dementia affecting specifically older population. AD is an irreversible neurodegenerative CNS disorder associated with complex pathophysiology. Presently, the USFDA has approved only four drugs viz. Donepezil, Rivastigmine, Memantine, and Galantamine for the treatment of AD. These drugs exhibit their neuroprotective effects either by inhibiting cholinesterase enzyme (ChE) or N-methyl-d-aspartate (NMDA) receptor. However, the conventional therapy "one target, one molecule" has failed to provide promising therapeutic effects due to the multifactorial nature of AD. This triggered the development of a novel strategy called Multi-Target Directed Ligand (MTDL) which involved designing one molecule that acts on multiple targets simultaneously. The present review discusses the detailed pathology involved in AD and the various MTDL design strategies bearing different heterocycles, in vitro and in vivo activities of the compounds, and their corresponding structure-activity relationships. This knowledge will allow us to identify and design more effective MTDLs for the treatment of AD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseHumansCholinesterase InhibitorsLigandsDonepezilRivastigmineAcetylcholinesterase

Stichwörter der Autor:innen

AcetylcholinesteraseAlzheimer’s diseaseAmyloid β aggregationButyrylcholinesteraseCholinesterase inhibitorsDementiaMulti-target directed ligandOxidative stress

Substanzen

Cholinesterase InhibitorsLigandsDonepezilRivastigmineAcetylcholinesterase

Autor:innen und Institutionen

  • Department of Pharmaceutical Chemistry, Parul Institute of Pharmacy, Parul University, Vadodara, Gujarat, India.
  • Department of Pharmaceutical Chemistry, Parul Institute of Pharmacy, Parul University, Vadodara, Gujarat, India. Electronic address: uma.kabra16205@paruluniversity.ac.in.

Zitieren

APA

Pathak, C., & Kabra, U. D. (2024). A comprehensive review of multi-target directed ligands in the treatment of Alzheimer’s disease. Bioorganic Chemistry, 144, 107152. https://doi.org/10.1016/j.bioorg.2024.107152

Vancouver

Pathak C, Kabra UD. A comprehensive review of multi-target directed ligands in the treatment of Alzheimer’s disease. Bioorganic Chemistry. 2024;144:107152. doi:10.1016/j.bioorg.2024.107152

BibTeX
@article{Pathak2024,
  author = {Pathak, Chandni and Kabra, Uma D},
  title = {A comprehensive review of multi-target directed ligands in the treatment of Alzheimer’s disease},
  journal = {Bioorganic Chemistry},
  year = {2024},
  volume = {144},
  pages = {107152},
  doi = {10.1016/j.bioorg.2024.107152}
}
Kostenlos starten →